Quinazoline derivatives with dual EGFR and VEGFR-2 inhibition: insights from docking, molecular dynamics, and in vivo studies
Tumor growth, angiogenesis, and metastasis are influenced by EGFR and VEGFR-2; therefore, dual targeting of EGFR and VEGFR-2 is an attractive approach for cancer management. Here, novel quinazoline analogues 4–23 were designed and synthesized as dual EGFR and VEGFR-2 TK inhibitors. In vitro enzymatic inhibitory activit...